AAGroup logo.jpg
American Airlines Announces Pricing of Senior Secured Notes
February 08, 2023 19:30 ET | American Airlines, Inc.
FORT WORTH, Texas, Feb. 08, 2023 (GLOBE NEWSWIRE) -- American Airlines, Inc. (the “Company”), a subsidiary of American Airlines Group Inc. (the “Guarantor”)(NASDAQ: AAL), today announced that it...
GlobalNewsWire Fluence Logo_Square.png
Fluence Energy, Inc. Reports First Quarter Fiscal 2023 Results
February 08, 2023 19:07 ET | Fluence
ARLINGTON, Va., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a leading global pure-play provider of energy storage products and services as...
Regeneron Logo.jpg
EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
February 08, 2023 18:45 ET | Regeneron Pharmaceuticals, Inc.
ROP is a leading cause of childhood blindness worldwide EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis TARRYTOWN, N.Y., Feb. 08, 2023 (GLOBE NEWSWIRE) --...
mesologo.png
FDA Grants Regenerative Medicine Advanced Therapy (Rmat) Designation for Rexlemestrocel-L in Chronic Low Back Pain
February 08, 2023 18:09 ET | Mesoblast Limited
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States...
MediciNova, Inc. Logo
MediciNova Announces Health Canada Grants Authorization to Commence Multi-arm Phase 2/3 Clinical Trial to Evaluate MN-166 (ibudilast) in Long COVID
February 08, 2023 18:00 ET | MediciNova, Inc.
LA JOLLA, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
Picture1.png
Lucy Scientific Discovery Inc. NASDAQ:LSDI Announces Pricing of $7.5 Million IPO
February 08, 2023 17:40 ET | Lucy Scientific Discovery. Inc.
VICTORIA, British Columbia, Feb. 08, 2023 (GLOBE NEWSWIRE) --  Lucy Scientific Discovery Inc. ( “the Company”), an early-stage psychotropics contract manufacturing company focused on becoming the...
Prospect_Capital_Logo_FINAL_RGB_0-117-188-01.jpg
Prospect Capital Announces December 2022 Results: $0.23 per Common Share Basic Net Investment Income and Stable Monthly $0.06 per Common Share Distributions
February 08, 2023 17:05 ET | Prospect Capital Corporation
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended December 31, 2022....
Embecta_Logo.jpg
embecta to Participate in Upcoming Investor Conferences
February 08, 2023 17:00 ET | Embecta Corp.
PARSIPPANY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will...
Cara logo transparent background 011123.png
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
February 08, 2023 17:00 ET | Cara Therapeutics, Inc.
STAMFORD, Conn., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of...
Fulcrum-Logo_Primary_Full-Color_RGB_Large copy.jpg
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
February 08, 2023 17:00 ET | Fulcrum Therapeutics, Inc.
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically...